SMAD4 and head and neck squamous cell carcinoma: In addition to EGFR, the rate of Smads mutations is also low in OSCC tissues, although current evidence suggests that the deletion of Smad4 contributes to the metastasis of head and neck squamous cell carcinoma (HNSCC).